Sensus Healthcare, Inc. (SRTS) Cash and securities
- Total cash · latest quarter (USD): Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30..
- Cash per share · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30..
Cash and securities
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total cash · latest quarter (USD) | (m) | Cash and cash equivalents plus current marketable securities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Cash per share · latest quarter | (m) | Cash and cash equivalents plus current marketable securities / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash and equivalents | 15.19M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total cash | Cash per share | Cash and equivalents (USD) | Short-term securities (USD) | Quarter-end shares (shares) |
|---|---|---|---|---|---|
| 2026-06-30 | (m) | (m) | $15.19M | (m) | (m) |
| 2026-03-31 | (m) | (m) | $18.33M | (m) | (m) |
| 2025-12-31 | (m) | (m) | $22.08M | (m) | (m) |
| 2025-09-30 | (m) | (m) | $24.45M | (m) | (m) |
| 2025-06-30 | (m) | (m) | $22.16M | (m) | (m) |
| 2025-03-31 | (m) | (m) | $19.07M | (m) | (m) |
| 2024-12-31 | (m) | (m) | $22.06M | (m) | (m) |
| 2024-09-30 | (m) | (m) | $22.56M | (m) | (m) |
| 2024-06-30 | (m) | (m) | $18.97M | (m) | (m) |
| 2024-03-31 | (m) | (m) | $14.73M | (m) | (m) |
| 2023-12-31 | (m) | (m) | $23.15M | (m) | (m) |
| 2023-09-30 | (m) | (m) | $20.49M | (m) | (m) |
| 2023-06-30 | (m) | (m) | $20.05M | (m) | (m) |
| 2023-03-31 | (m) | (m) | $19.34M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $25.52M | (m) | (m) |
| 2022-09-30 | (m) | (m) | $37.58M | (m) | (m) |
| 2022-06-30 | (m) | (m) | $33.70M | (m) | (m) |
| 2022-03-31 | (m) | (m) | $32.83M | (m) | (m) |
| 2021-12-31 | (m) | (m) | $14.52M | (m) | (m) |
| 2021-09-30 | (m) | (m) | $16.39M | (m) | (m) |
| 2021-06-30 | (m) | (m) | $15.20M | (m) | (m) |
| 2021-03-31 | (m) | (m) | $13.65M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $14.91M | (m) | (m) |
| 2020-09-30 | (m) | (m) | $16.13M | (m) | (m) |
| 2020-06-30 | (m) | (m) | $18.41M | (m) | (m) |
| 2020-03-31 | (m) | (m) | $12.10M | (m) | (m) |
| 2019-12-31 | (m) | (m) | $8.10M | (m) | (m) |
| 2019-09-30 | (m) | (m) | $6.91M | (m) | (m) |
| 2019-06-30 | (m) | (m) | $11.43M | (m) | (m) |
| 2019-03-31 | (m) | (m) | $6.25M | (m) | (m) |
| 2018-12-31 | (m) | (m) | $12.48M | (m) | (m) |
| 2018-09-30 | (m) | (m) | $17.12M | (m) | (m) |
| 2018-06-30 | (m) | (m) | $8.01M | (m) | (m) |
| 2018-03-31 | (m) | (m) | $9.52M | (m) | (m) |
| 2017-12-31 | (m) | (m) | $10.09M | (m) | (m) |
| 2017-09-30 | (m) | (m) | $6.84M | (m) | (m) |
| 2017-06-30 | (m) | (m) | $4.22M | (m) | (m) |
| 2017-03-31 | (m) | (m) | $3.14M | (m) | (m) |
| 2016-12-31 | (m) | (m) | $5.04M | (m) | (m) |
| 2016-09-30 | (m) | (m) | $4.61M | (m) | (m) |
| 2016-06-30 | (m) | (m) | $15.76M | (m) | (m) |
| 2016-03-31 | (m) | (m) | $4.75M | (m) | (m) |
| 2015-12-31 | (m) | (m) | $5.07M | (m) | (m) |
| 2015-09-30 | (m) | (m) | $3.43M | (m) | (m) |
| 2015-06-30 | (m) | (m) | $3.88M | (m) | (m) |
| 2014-12-31 | (m) | (m) | $4.54M | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B |